TheStreet – Hedge Fund SAC Capital Advisors is being investigated by the Securities and Exchange Commission into whether traders used inside information to profit from the $15 billion takeover of MedImmune in 2007, The Wall Street Journal reported.
The investigation is part of a broad SEC inquiry into trading by hedge funds in stocks connected to some of the biggest health care deals of the past decade, the Journal said, citing people familiar with the matter.
